PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurosurgery, Naval Medical Center San Diego, San Diego, California, United States of America.\', \'Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, United States of America.\', \'Department of Neurology, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, United States of America.\', \'Research Analytics, Vizient Inc., Irving, Texas, United States of America.\', \'Department of Neurology, University of Washington, Seattle, Washington, United States of America.\', \'Department of Neurology, NYU Langone Health, New York, New York, United States of America.\', \'Department of Neurology, Brown University, Providence, Rhode Island, United States of America.\', \'Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0248728
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33852591
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all